Encounters Queue

5 Active Inpatients

Active patient triage, real-time documentation quality, and ATS/IDSA clinical risk stratification.

Sarah Al-Otaibi

Day 3

71y • Female • MRN 882934

PRIMARY DEMO ANCHOR Action Required (68%)

Primary Diagnosis

Community-Acquired Pneumonia (CAP)

Room: 402-B • Internal Medicine

Documentation Quality 68%

Research Readiness 72%

Pending LIS Labs ACO Specificity Needed CURB-65 = 1

Fatima Al-Harbi

64y • Female • MRN 990238

In Review

Primary Diagnosis

Acute Decompensated Heart Failure

Room: 204-C • Cardiology

Quality 82%

Mohammed Al-Ghamdi

58y • Male • MRN 128472

Compliant

Primary Diagnosis

Acute Exacerbation of Bronchial Asthma

Room: 310-A • Internal Medicine

Quality 95%

Abdullah Al-Shehri

82y • Male • MRN 447190

Critical Gaps

Primary Diagnosis

Post-Op Colectomy Sepsis

Room: 108-D • Surgery

Quality 58%

Noura Al-Dossari

49y • Female • MRN 551209

In Review

Primary Diagnosis

Atrial Fibrillation with RVR

Room: 202-A • Cardiology

Quality 78%

Step 2: Patient Record

SA

Sarah Al-Otaibi

71y F Inpatient Day 3

MRN: 882934 Admission: 2026-08-16 Room: 402-B Attending: Dr. Mohammed

Blood Pressure

118 / 74

Normotensive

Heart Rate

78 bpm

Normal Sinus

Temperature

37.1 °C

Afebrile (>24h)

O2 Saturation

98%

Room Air (Off O2)

Cerner LIS Synchronized Lab Results (Aug 18):

White Blood Cells (WBC)

8.2 x 10^9/L

Admission: 14.1 (Resolved)

C-Reactive Protein (CRP)

6.5 mg/L

Admission: 45.0 (85% Drop)

Procalcitonin

0.11 ng/mL

Normal Range < 0.25 ng/mL

Step 3: Clinical Document (EHR Note & Editor)

Clinical Progress Note & Step-Down Order

Day 3 Inpatient Auto-Saved EHR Cache

Patient: Sarah Al-Otaibi (MRN: 882934) Powered by strict evaluateClinicalNote PRD engine with dynamic two-way reactivity.

Macros:

Words: 110 Characters: 742

1. Subjective (HPI, ROS, Interval History) HPI Recorded

Character count: 215 | Matched CAP Elements: 8/11 Interval History Documented

2. Objective (Vitals, Physical Exam & Lab Findings) LIS Biomarkers Pending

Missing In Note Cerner LIS Batch: WBC 8.2 x10^9/L, CRP 6.5 mg/L, Procalcitonin 0.11 ng/mL

Character count: 218 | Matched CAP Elements: 8/11 Click [+ Insert] to raise score to 78%

3. Assessment & Clinical Problem List ACO Specificity Needed

Coding Gap Mild Asthma (Unspecified chronic airway disease)

Character count: 104 | Matched CAP Elements: 8/11 Click [+ Clarify] to raise score to 86%

4. Plan (Antimicrobial Stewardship & Step-Down) Duration Vague

Stewardship Gap Continue antibiotic therapy (duration unquantified)

Character count: 128 | Matched CAP Elements: 8/11 Click [+ Apply] to reach 92% (Compliant)

DocIQ Intelligence Gauge

68% (Needs Attention)

68% DEFICIENT

Live PRD Evaluation Engine

Accept the 3 AI suggestions on the left to elevate documentation to 92% (Excellent).

1. Completeness Weight (40%) 29.09 pts (8/11 items)

2. Diagnostic Precision (20%) 13.00 pts

3. Consistency & Logic (20%) 12.00 pts

4. SOAP Structure (20%) 20.00 pts

Documentation Gaps & Action Items 3 Actions Pending

Objective: Inflammatory kinetics (WBC & CRP) missing from progress note.

Assessment: Asthma-COPD Overlap specificity unstated (needed for RWE registry).

Plan: Oral step-down dosing target (7 days) unquantified.

> Official ATS/IDSA CAP Criteria

Biomarkers: CRP 6.5 mg/L (85% reduction) clears patient for step-down.

Stewardship: 7-day target (Amox/Clav 875/125mg PO BID).

Severity: CURB-65 = 1 safely managed in ward.

Step 4: Clinical Review & CAP Checklist

ATS/IDSA Criteria

11-Point CAP documentation checklist dynamically evaluated by evaluateClinicalNote.

8 / 11 Completed (73%)

1. Patient Demographics & Age

Validated with EHR Registry (Sarah Al-Otaibi, 71y, MRN 882934).

Compliant ✓✓

2. Chief Complaint

Documented pleuritic chest pain & productive cough.

Compliant ✓✓

3. History of Present Illness (HPI)

Day 3 interval symptom review & resolution trajectory.

Compliant ✓✓

4. Review of Systems (ROS)

Negative for chills, fever resolved >24h.

Compliant ✓✓

5. Inpatient Active Medications

IV Ceftriaxone, Losartan 50mg, Albuterol.

Compliant ✓✓

6. Allergy Assessment

No Known Drug Allergies (NKDA) confirmed.

Compliant ✓✓

7. Physical Exam & Lung Sounds

Light end-inspiratory crackles RLL documented.

Compliant ✓✓

8. Bedside Vitals Telemetry

BP 118/74, Temp 37.1 °C, HR 78, SpO2 98% room air.

Compliant ✓✓

9. Inflammatory Biomarkers (WBC / CRP)

Cerner LIS LOINC WBC 8.2 x10^9/L & CRP 6.5 mg/L.

10. Comorbidity Specificity (ACO J44.9)

Asthma-COPD Overlap ICD-10 precision.

11. Antimicrobial Stewardship Plan

Oral Amoxicillin-Clavulanate 875/125mg BID 7-day target.

> > > Step 5: AI Recommendations & Clinical Decision Support (CDS) >

Clinical Decision Support & Stewardship Hub

ATS/IDSA Certified

Real-time Evidence-Based CDS • 3 Tailored Interventions for Sarah Al-Otaibi (MRN: 882934)

• Protocol Compliance: 100% (ATS/IDSA Aligned) • Stewardship: Step-Down Qualified (Afebrile >24h) • Research Fit: USCDI v6.0 Verified

Antimicrobial Stewardship

Grade A Evidence • ATS/IDSA

Current Inpatient Regimen:

IV Ceftriaxone 1g IV Q24H (Day 3)

⚠️ Flagged for early oral step-down conversion

AI Step-Down Target:

Amoxicillin-Clavulanate 875/125mg PO BID

Target Duration: 7 Days Total (Complete 4 days outpatient)

Clinical Stability Rationale:

Patient is hemodynamically normotensive (118/74), afebrile x 24h (37.1 °C), SpO2 98% on room air, and CRP dropped by 85% (from 45 to 6.5 mg/L).

Pulmonary Care & ACO Follow-Up

Grade B Evidence • GOLD 2024

Target Chronic Condition:

Asthma-COPD Overlap (ACO)

ICD-10 J44.9 / J45.30 Specified

Recommended Follow-Up Protocol:

• Schedule outpatient spirometry & inhaler technique review within 5-7 days post-discharge.
• Continue home maintenance: Inhaled Corticosteroid + LABA

30-Day Readmission Prevention:

Early pulmonary clinic follow-up within 7 days reduces 30-day post-pneumonia readmissions by 34% in elderly patients with chronic airway obstruction.

RWE Registry & USCDI Readiness

USCDI v6.0 • FHIR R4 Ready

Research Impact:

Qualifies encounter for the National Multi-Center Pneumonia Real-World Evidence (RWE) Observational Cohort.

Data Completeness Checklist:

✓ Discrete Biomarker Kinetics (WBC, CRP, Procalcitonin)

✓ Validated Comorbidity ICD-10 Specificity (J44.9 / J45.30)

✓ Standardized LOINC & SNOMED CT Terminology

Research Readiness Index: 89% (High Quality)

Decision Support Governance & Protocol Source

Derived from ATS/IDSA 2024 Community-Acquired Pneumonia Guidelines & Global Antimicrobial Stewardship Protocols.

⚠️

Documentation Completeness Advisory

Note: 3 ATS/IDSA recommendations remain unaddressed. Clinician attestation will record override in the audit log.

Step 7: Finalize Clinical Record

Draft (Unsigned)

Cryptographic SHA-256 provenance stamping and immediate FHIR R4 document bridge synchronization.

KING FAHD UNIVERSITY MEDICAL CENTER • INPATIENT CARE

CLINICAL PROGRESS NOTE & STEP-DOWN

Patient: Sarah Al-Otaibi

MRN: 882934 • Attending: Dr. Mohammed

SUBJECTIVE:

71-year-old female admitted for pneumonia with history of mild asthma. Today reports feeling better, cough is improving, and pleuritic chest pain has decreased. No fevers reported in the last 24 hours.

OBJECTIVE:

Vitals (Day 3): Temp: 37.1 °C (afebrile x 24h), BP: 118/74 mmHg, HR: 78 bpm, RR: 16, SpO2: 98% on room air. Physical Exam: Light end-inspiratory crackles right lower lobe, improving compared to Day 1. No wheezing.

ASSESSMENT:

1. Community-Acquired Pneumonia (CAP) - Improving. 2. Mild Asthma - Stable. 3. Hypertension - Controlled.

PLAN:

Continue IV antibiotics and supportive respiratory care. Monitor vitals. Plan discharge when clinically ready.

🔒

Dr. Mohammed, MD • Attending Physician Unsigned Draft

Audit Hash: sha256-df9b2a7d4fcbdad279e61209b44c52e71fa01 • 2026-08-27T18:50:00Z

Encounters Queue

Sarah Al-Otaibi

Fatima Al-Harbi

Mohammed Al-Ghamdi

Abdullah Al-Shehri

Noura Al-Dossari

Sarah Al-Otaibi

Clinical Progress Note & Step-Down Order

Step 4: Clinical Review & CAP Checklist

1. Patient Demographics & Age

2. Chief Complaint

3. History of Present Illness (HPI)

4. Review of Systems (ROS)

5. Inpatient Active Medications

6. Allergy Assessment

7. Physical Exam & Lung Sounds

8. Bedside Vitals Telemetry

9. Inflammatory Biomarkers (WBC / CRP)

10. Comorbidity Specificity (ACO J44.9)

11. Antimicrobial Stewardship Plan

Clinical Decision Support & Stewardship Hub

Antimicrobial Stewardship

Pulmonary Care & ACO Follow-Up

RWE Registry & USCDI Readiness

Dual Scoring Engine

Documentation Quality Score

Research Readiness Score

Step 7: Finalize Clinical Record

CLINICAL PROGRESS NOTE & STEP-DOWN

HL7 FHIR R4 Clinical Document Bundle

Audit Trail & Cryptographic Provenance Log